Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicon ; 162: 32-39, 2019 Apr 15.
Article in English | MEDLINE | ID: mdl-30849455

ABSTRACT

Lonomia obliqua is a caterpillar of potential therapeutic interest whose venom is able to induce severe blood leakage and modulate leukocyte migration. Since both phenotypes are associated with changes in cytoskeleton dynamics and cell adhesion properties, the aim of this study was to analyze the effects of Lonomia obliqua bristle extract (LOBE) in cell adhesion and migration signaling. Proteomic analysis revealed that epithelial cells (CHO-K1) exposed to LOBE (30 µg/mL, 30 min) exhibited changes in levels of actin regulatory proteins, including RhoGTPases. These changes correlated with an increase in the activity of the RhoGTPase family member Rac as measured by Förster resonance energy transfer (FRET). When plated in migration promoting conditions, CHO-K1 cells exposed to LOBE (10 µg/mL) showed an increase in membrane ruffling after short (30 min) period of incubation that was accompanied by changes in the distribution of the adhesion markers paxillin, vinculin and an increase of focal adhesion kinase autophosphorylation levels (Y397), suggesting changes in cell-extracellular matrix (ECM) adhesion properties and signaling. These data suggest that LOBE possesses bioactive molecules that are capable to modulated cell migration signaling, cytoskeletal dynamics and cell-ECM properties of several cell types.


Subject(s)
Arthropod Venoms/toxicity , Cell Adhesion/drug effects , Moths/chemistry , rac1 GTP-Binding Protein/metabolism , Actins/metabolism , Animals , CHO Cells , Cell Movement/drug effects , Cricetulus , Cytoskeleton/physiology , Larva/chemistry , Paxillin/metabolism , Phosphorylation , Proteome/analysis , Vinculin/metabolism
2.
Biochem Biophys Res Commun ; 485(4): 814-819, 2017 04 15.
Article in English | MEDLINE | ID: mdl-28257847

ABSTRACT

An early step of target validation in antimicrobial drug discovery is to prove that a gene coding for a putative target is essential for pathogen's viability. However, little attention has been paid to demonstrate the causal links between gene essentiality and a particular protein function that will be the focus of a drug discovery effort. This should be considered an important step in target validation since a growing number of proteins are found to exhibit multiple and unrelated tasks. Here, we show that the Mycobacterium tuberculosis (Mtb) folB gene is essential and that this essentiality depends on the dihydroneopterin aldolase/epimerase activities of its protein product, the FolB protein from the folate biosynthesis pathway. The wild-type (WT) MtFolB and point mutants K99A and Y54F were cloned, expressed, purified and monitored for the aldolase, epimerase and oxygenase activities using HPLC. In contrast to the WT MtFolB, both mutants have neither aldolase nor epimerase activities in the conditions assayed. We then performed gene knockout experiments and showed that folB gene is essential for Mtb survival under the conditions tested. Moreover, only the WT folB sequence could be used as a rescue copy in gene complementation studies. When the sequences of mutants K99A or Y54F were used for complementation, no viable colonies were obtained, indicating that aldolase and/or epimerase activities are crucial for Mtb survival. These results provide a solid basis for further work aiming to develop new anti-TB agents acting as inhibitors of the aldolase/epimerase activities of MtFolB.


Subject(s)
Aldehyde-Lyases/antagonists & inhibitors , Antitubercular Agents/pharmacology , Bacterial Proteins/antagonists & inhibitors , Drug Discovery/methods , Mycobacterium tuberculosis/drug effects , Aldehyde-Lyases/genetics , Aldehyde-Lyases/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biocatalysis , Chromatography, High Pressure Liquid , Genes, Essential/genetics , Genetic Complementation Test/methods , Humans , Microbial Viability/drug effects , Microbial Viability/genetics , Molecular Targeted Therapy/methods , Mutation, Missense , Mycobacterium tuberculosis/enzymology , Mycobacterium tuberculosis/genetics , Reproducibility of Results , Substrate Specificity , Tandem Mass Spectrometry , Tuberculosis/drug therapy , Tuberculosis/microbiology
3.
Arch Biochem Biophys ; 465(1): 11-5, 2007 Sep 01.
Article in English | MEDLINE | ID: mdl-17543881

ABSTRACT

Snake venom metalloproteinases (SVMPs) in Viperid venoms primarily function to give rise to local and systemic hemorrhage following snake envenomation. Years of research on these toxins, both in vitro and in vivo, indicate that they function by disrupting capillary basement membranes, stromal matrix and cell-cell and cell-matrix contacts to allow escape of capillary contents under pressure. However, most of these studies used either defined substrates in vitro or were limited by relevant antibodies for detection of sites of action in vivo. In this investigation we use stable isotope-labeled amino acids in culture (SILAC) to determine novel proteolytic activities for exogenously added atrolysin A, a hemorrhagic PIII SVMP isolated from Crotalus atrox venom. When comparing the solubilized products of SILAC-labeled cultured human fibroblasts treated with atrolysin A to that of untreated fibroblasts using LC/MS/MS, several proteins were identified as being released into the culture media specifically due to atrolysin A proteolytic activity. These included collagen VI, fibronectin, fibulin 2 and annexin V. Of particular interest was the observation of collagen VI and annexin V in that the release of these substrates could play a role in altering hemostasis and promote hemorrhage caused by the more typical actions of atrolysin A. In summary, this study demonstrates the utility of SILAC for exploring sheddase activity with cells in culture and suggests the presence of two novel substrates for SVMPs that may play a pathological role in altering host hemostasis during envenomation.


Subject(s)
Extracellular Matrix Proteins/metabolism , Extracellular Matrix/metabolism , Fibroblasts/metabolism , Gene Expression Profiling/methods , Hydrolases/metabolism , Mass Spectrometry/methods , Metalloendopeptidases/administration & dosage , Cell Line , Crotalid Venoms/administration & dosage , Dose-Response Relationship, Drug , Extracellular Matrix/drug effects , Fibroblasts/drug effects , Humans , Isotope Labeling/methods , Substrate Specificity/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...